COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,254 Articles (22,733 medRxiv, 8,521 bioRxiv)

Most recent first Previous |  Page 2116: Articles 21151-21160  | Next

PRAK-03202: A triple antigen VLP vaccine candidate against SARS CoV-2
Mazumder, S., Rastogi, R., Undale, A., Arora, K., Arora, N. M., Das Purkayastha, B. P., Kumar, D., Joseph, A., Mali, B., Arya, V. B., Kalyanaraman, S., Mukherjee, A., Gupta, A., Potdar, S., Roy, S. S., Parashar, D., Paliwal, J., Singh, S. K., Naqvi, A., Srivastava, A., Singh, M. K., Kumar, D., Bansal, S., Rautray, S., Singh, I., Fengade, P., Kumar, B., Saini, M., Jain, K., Gupta, R., Kundu, P. K.
10.1101/2020.10.30.360115 — Posted: 2020-10-30
A cell-free antibody engineering platform rapidly generates SARS-CoV-2 neutralizing antibodies
Chen, X., Gentili, M., Hacohen, N., Regev, A.
10.1101/2020.10.29.361287 — Posted: 2020-10-30
COVID Moonshot: Open Science Discovery of SARS-CoV-2 Main Protease Inhibitors by Combining Crowdsourcing, High-Throughput Experiments, Computational Simulations, and Machine Learning
The COVID Moonshot Consortium, , Achdout, H., Aimon, A., Bar-David, E., Barr, H., Ben-Shmuel, A., Bennett, J., Bobby, M. L., Brun, J., BVNBS, S., Calmiano, M., Carbery, A., Cattermole, E., Chodera, J. D., Clyde, A., Coffland, J. E., Cohen, G., Cole, J., Contini, A., Cox, L., Cvitkovic, M., Dias, A., Douangamath, A., Duberstein, S., Dudgeon, T., Dunnett, L., Eastman, P. K., Erez, N., Fairhead, M., Fearon, D., Fedorov, O., Ferla, M., Foster, H., Foster, R., Gabizon, R., Gehrtz, P., Gileadi, C., Giroud, C., Glass, W. G., Glen, R., Glinert, I., Gorichko, M., Gorrie-Stone, T., Griffen, E. J., Heer, J., Hill, M., Horrell, S., Hurley, M. F. D., Israely, T., Jajack, A., Jnoff, E., John, T., Kantsadi, A. L., Kenny, P. W., Kiappes, J. L., Koekemoer, L., Kovar, B., Krojer, T., Lee, A. A., Lefker, B. A., Levy, H., London, N., Lukacik, P., Macdonald, H. B., MacLean, B., Malla, T. R., Matviiuk, T., McCorkindale, W., Melamed, S., Michurin, O., Mikolajek, H., Morris, A., Morris, G. M., Morwitzer, M. J., Moustakas, D., Neto, J. B., Oleinikovas, V., Overheul, G. J., Owen, D., Pai, R., Pan, J., Paran, N., Perry, B., Pingle, M., Pinjari, J., Politi, B., Powell, A., Psenak, V., Puni, R., Rangel, V. L., Reddi, R. N., Reid, S. P., Resnick, E., Robinson, M. C., Robinson, R. P., Rufa, D., Schofield, C., Shaikh, A., Shi, J., Shurrush, K., Sittner, A., Skyner, R., Smalley, A., Smilova, M. D., Spencer, J., Strain-Damerell, C., Swamy, V., Tamir, H., Tennant, R., Thompson, A., Thompson, W., Tomasio, S., Tumber, A., Vakonakis, I., van Rij, R. P., Varghese, F. S., Vaschetto, M., Vitner, E. B., Voelz, V., von Delft, A., von Delft, F., Walsh, M., Ward, W., Weatherall, C., Weiss, S., Wild, C. F., Wittmann, M., Wright, N., Yahalom-Ronen, Y., Zaidmann, D., Zidane, H., Zitzmann, N.
10.1101/2020.10.29.339317 — Posted: 2020-10-30
Amino acid transporter B0AT1 influence on ADAM17 interactions with SARS-CoV-2 receptor ACE2 putatively expressed in intestine, kidney, and cardiomyocytes
Andring, J. T., McKenna, R., Stevens, B. R.
10.1101/2020.10.30.361873 — Posted: 2020-10-30
Brilacidin, a COVID-19 Drug Candidate, Exhibits Potent In Vitro Antiviral Activity Against SARS-CoV-2
Bakovic, A., Risner, K., Bhalla, N., Alem, F., Chang, T. L., Weston, W., Harness, J. A., Narayanan, A.
10.1101/2020.10.29.352450 — Posted: 2020-10-30 Discussion: Onsite | Offsite
The psychological impact of coronavirus on university students and its socio-economic determinants in Malaysia
Irfan, M., Shahudin, F., HOOPER, V., Akram, W., Ghani, R.
10.1101/2020.10.27.20220723 — Posted: 2020-10-30 Discussion: Onsite
Association of County-Wide Mask Ordinances with Reductions in Daily CoVID-19 Incident Case Growth in a Midwestern Region Over 12 Weeks
Shacham, E., Scroggins, S., Ellis, M., Garza, A.
10.1101/2020.10.28.20221705 — Posted: 2020-10-30 Discussion: Offsite
Trip duration drives shift in travel network structure with implications for the predictability of spatial disease spread
Giles, J. R., Cummings, D. A., Grenfell, B. T., Tatem, A. J., Erbach- Schoenberg, E. z., Metcalf, C. J. E., Wesolowski, A.
10.1101/2020.10.27.20215566 — Posted: 2020-10-30
The COVID-19 Healthcare Personnel Study (CHPS): Overview, Methods and Preliminary Report
The COVID-19 Healthcare Personnel Study (CHPS), , DiMaggio, C., Abramson, D., Susser, E., Hoven, C., Chen, Q., Andrews, H., Herman, D., Kreniske, J., Ryan, M., Susser, I., Thorpe, L., Li, G.
10.1101/2020.10.29.20222372 — Posted: 2020-10-30
Mental Health Impact of the First Wave of COVID-19 Pandemic on Spanish Healthcare Workers: a Large Cross-sectional Survey
Alonso, J., Vilagut, G., Mortier, P., Ferrer, M., Alayo, I., Aragon-Pena, A., Aragones, E., Campos, M., del Cura-Gonzalez, I., Emparanza, J. I., Espuga, M., Forjaz, J., Gonzalez Pinto, A., Haro, J. M., Lopez Fresnena, N., Martinez de Salazar, A., Molina, J. D., Orti Lucas, R. M., Parellada, M., Pelayo-Teran, J. M., Perez Zapata, A., Pijoan, J. I., Plana, N., Puig, T., Rius, C., Rodriguez-Blazquez, C., Sanz, F., Serra, C., Kessler, R. C., Bruffaerts, R., Vieta, E., Perez-Sola, V., MINDCOVID Working group
10.1101/2020.10.27.20220731 — Posted: 2020-10-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).